Antibiotic and Steroid Eye Drops for Bacterial Conjunctivitis
For bacterial conjunctivitis, prescribe a topical fluoroquinolone antibiotic (such as moxifloxacin 0.5%, levofloxacin 0.5%, or gatifloxacin 0.5%) 4 times daily for 5-7 days; add topical corticosteroids ONLY if there is severe inflammation after 2-3 days of antibiotic therapy showing clinical improvement, and only after ruling out viral (especially herpes) or fungal infection.
Antibiotic Selection and Dosing
The primary treatment for bacterial conjunctivitis centers on topical antibiotics. Based on pediatric and adult guidelines, fluoroquinolones are the preferred first-line agents due to their broad-spectrum coverage against common pathogens including Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus 1.
Recommended Antibiotic Options:
- Moxifloxacin 0.5%: 1 drop 4 times daily for 7 days
- Levofloxacin 0.5%: 1 drop 4 times daily for 7 days
- Gatifloxacin 0.5%: 1 drop 4 times daily for 7 days
- Besifloxacin 0.6%: 1 drop 3 times daily for 7 days
- Ciprofloxacin 0.3%: 1 drop 4 times daily for 7 days
All these agents are FDA-approved for bacterial conjunctivitis in adults and children ≥12 months of age 1. Systemic toxicity is not a concern with topical therapy 1.
Important Clinical Context:
Bacterial conjunctivitis is frequently self-limiting - approximately 64% of cases resolve spontaneously by days 2-5 without treatment 2. However, antibiotics increase clinical cure rates by 26% (from 55.5% to 68.2%) and microbiological cure by 53% 3, 2. The number needed to treat is 5, meaning you need to treat 5 patients to achieve one additional cure 4, 2.
Corticosteroid Use: A Conservative Approach
The addition of topical corticosteroids to antibiotics in bacterial conjunctivitis is controversial and should be approached with extreme caution. Here's the algorithmic approach:
When to AVOID Corticosteroids:
- Initial presentation of bacterial conjunctivitis (always start with antibiotics alone)
- Any suspicion of viral conjunctivitis (especially herpes simplex)
- Fungal infection not ruled out
- Nocardia infection (corticosteroids result in poor visual outcomes) 5
- Epithelial defect not yet healing
When to CONSIDER Adding Corticosteroids:
Only after meeting ALL of these criteria:
- Minimum 2-3 days of progressive improvement on antibiotic therapy 5
- Organism identified (bacterial, not viral/fungal) 5
- Epithelial defect is healing 5
- Severe inflammation compromising the central cornea 5
If Corticosteroids Are Added:
Dosing:
- Prednisolone acetate 1% or dexamethasone 0.1%: 1 drop 2-4 times daily
- Use the minimum effective dose to control inflammation 5
- Taper slowly once inflammation is controlled 6
Monitoring Requirements:
- Re-examine within 1-2 days after initiating steroids 5
- Monitor intraocular pressure (IOP) at each visit 5
- For therapy >8 weeks: obtain baseline retinal nerve fiber layer OCT and regular ophthalmology supervision 7
- Discuss risks of cataract and glaucoma with patient 5
Evidence on Combination Therapy:
A 2012 study demonstrated that fixed-combination moxifloxacin 0.5%/dexamethasone 0.1% achieved 81.6% clinical resolution in bacterial blepharitis with conjunctivitis, with excellent tolerability 8. However, this was in selected cases with both infection and inflammation.
Historical data from 1976 showed that corticosteroids were more effective than antibiotics alone in suppressing conjunctival inflammation, with no serious complications in short-term use 9. A 2019 review suggested that short-term use (≤2 weeks) of steroid-antibiotic combinations could be effective and well-tolerated 10.
However, the most recent high-quality evidence from bacterial keratitis studies (which is more severe than conjunctivitis) shows no overall benefit of adding corticosteroids, except possibly in severe cases or Pseudomonas infections 5. The Steroids for Corneal Ulcer Trial (SCUT) found no benefit but also no increase in adverse events 5.
Critical Pitfalls to Avoid
Never use corticosteroids in suspected viral conjunctivitis - they prolong viral shedding and can worsen herpes simplex infections 6, 10
Avoid topical steroids at initial presentation - always establish bacterial etiology and response to antibiotics first 5
Don't use steroids for mild bacterial conjunctivitis - the self-limited nature and risks outweigh benefits 2
Monitor for steroid-induced complications: IOP elevation (risk increases with ≥2 drops/day), cataracts, and infectious crystalline keratopathy with chronic use 5, 11, 5
Warn patients about symptom rebound when tapering steroids - increased inflammation doesn't necessarily mean worsening infection 5
Special Populations
Children (<18 years): Same fluoroquinolone options are safe and effective 1. Systemic toxicity is not a concern with topical therapy 1.
Gonococcal/Chlamydial conjunctivitis: Requires systemic antibiotics (ceftriaxone 250mg IM for gonorrhea; azithromycin 1g PO for chlamydia) in addition to topical therapy 12.